ArticleCancer immunology, immunotherapy : CII2021

A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer.

A J R McGray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.